A study from the University of Verona sheds light on a new therapeutic strategy that may prevent the complications of sickle cell disease (SCD), a serious genetic disease that affects about 230,000 children worldwide every year in sub-Saharan Africa and 2600-1300 newborns in North America and Europe. In Italy, Sickle cell disease, once prevalent in Southern Italy, is now found throughout the country due to...

Leggi tutto...